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COVID-19 is a highly contagious disease caused by 
severe acute respiratory syndrome coronavirus-2 
(SARS-CoV-2), an enveloped positive stranded RNA 
virus and the third member of the family 
Coronaviridae which has emerged as a zoonotic 
infection (1-3). The predecessor of this new 
pathogen caused the Severe Acute Respiratory 
Syndrome (SARS) in 2003 and the Middle East 
Respiratory Syndrome (MERS) in 2012 (4, 5). 
Although corona viruses have been known since 
1960’s, their familiar species were human 
pathogens and caused common cold and seasonal 
flu (1, 2). SARS-CoV-2 is easily transmitted via 
respiratory secretions of an infected person, with a 
reproductive number (the average number of cases 
to which a single infected person will transmit the 
virus) of 1.4-2.5 (6). Covid-19 has been estimated to 
have a case fatality rate of around 3% (7). As of 
today, asymptomatic transmission is assumed to be 
possible during the incubation period, which 
usually ranges from 2-14 days. The source of 
infection, animal host, and reservoir are currently 
unknown (8, 9). 
In late December 2019, an outbreak of COVID-19 
was reported from Wuhan city, China (10). The 
disease soon spread outside China borders and 
became rapidly prevalent all around the world. The 
pandemic announcement was officially made by 
World Health Organization (WHO) on 11 March 
2020 (11). Today COVID-19 has affected more than 
212 countries and has made billions of people to be 
quarantined in their houses (12). Up to now, almost 
1500000 confirmed cases of COVID-19 have been 
reported globally and the death toll has been 
declared to be 86000. In Iran, we are also facing 
this unprecedented global public health 
emergency, with about 65000 confirmed cases and 
3993 deaths (13). 
This pandemic is beyond an expanding contagious 
disease and has influenced different features of life. 
Its enormous social, political, and specifically 
economic impacts all around the world are 
undeniable. In low- and middle-income countries 
this can potentially lead to a huge spike in poverty 
and collapse. Many vulnerable families have lost 
their income and access to the essential needs. 
Education systems have collapsed in many regions. 
The long-term effect of this global crisis has 
reduced economic growth even in developed 
countries. Economic effects of COVID-19 are 
estimated with dramatic variations. Orlik et al in 
Bloomberg hypothesized this cost to be $2.7 trillion 
(14). The political consequences are even harder to 
predict but quite significant and devastating, like 
the heated discussion, criticism and accusation 
flowing between the leaders of different countries. 
Since the pandemic is not yet over, the global 
influence will carry on to happen and make 
situation even more complicated.  
While the outbreak is evolving rapidly, health care 
systems across the world are actively fighting 
against the new virus. They have encountered 
many new challenges. Public health measures 
(such as active case finding, prompt isolation of 
cases and contacts tracing) to contain the spread of 
the disease in the society as well as provision of 
care for the unpredictably high number of people 
who are infected with the virus have stretched the 
healthcare system beyond its capacity. At the same 
time, protecting health care providers’ safety, 
which often requires provision of sufficient 
supplies of personal protective equipment, has 
definitely challenged the system. Societal demand 
for discovery of a definitive treatment and vaccine 
has also added to the complexity of the situation 
that the health care systems are facing.  
Studies about COVID-19 are increasingly being 
performed and published; many of them have not 
yet been fully reviewed and criticized by the 
academic community. Practitioners often find it 
difficult to find, appraise and apply the information 
they need amid the turbulence of their clinical 
practice. Furthermore, there are still many 
questions to be answered. The most efficient 
method for personal protection, methods of viral 
transmission, most accurate diagnostic 
approaches, and effective treatment options are yet 
to be determined.   
This special issue of the Advanced Journal of 
Emergency Medicine plans to specifically focus on 
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COVID-19 by gathering the relevant scientific 
information available. We hope that by publishing 
high quality papers, this journal can provide its 
readers with further required information. 
Appropriate management of patients suffering 
COVID-19 as well as controlling this pandemic are 
our ultimate aspirations. We encourage further 
researches in this field by all scientists and 
physicians all across the world to be able to 
eradicate COVID-19 as soon as possible. 
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